Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVERSE: Terlipressin for HRS Type 1
NCT01143246Phase 3Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Oct 2010
- Primary completion
- Feb 2013
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of terlipressin in hepatorenal syndrome type 1 (HRS-1), sponsored by Mallinckrodt Pharmaceuticals. Started Oct 2010; status: completed.
02
Drugs
terlipressin
03
Conditions
hepatorenal syndrome type 1 (HRS-1)
Beyond the preview
Go deeper on NCT01143246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01143246.